Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
NTRBW Stock Summary
In the News
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st. ORLANDO, FL / ACCESSWIRE / January 29, 2024 / Nutriband Inc. (Nasdaq:NTRB)(Nasdaq:NTRBW) today announced that it will be presenting at the Dealflow Events MicroCap Conference taking place January 30th through February 1 in Caesars Atlantic City.
Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023
ORLANDO, FL / ACCESSWIRE / April 19, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a pioneer in the development of innovative transdermal solutions, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 at 08:30 AM (Local Time -PST). Company CEO, Gareth Sheridan will be hosting the presentation and answering questions at the conclusion.
Nutriband Inc. to Present at the Emerging Growth Conference on May 25
Nutriband Inc. Invites Individual and Institutional Investors As Well as Advisors and Analysts, To Attend Its Real-Time, Interactive Presentation at the Emerging Growth Conference ORLANDO, FL / ACCESSWIRE / May 20, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), is pleased to announce that it has been invited to present at the Emerging Growth Conference on May 25, 2022. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO, Gareth Sheridan, in real time.
Nutriband Stock (NTRB): Why The Price Surged Today
The stock price of Nutriband Inc (NASDAQ: NTRB) increased by over 40% during intraday trading today. This is why it happened.
NTRBW Financial details
NTRBW Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-01-31
Metric | History | 2019-01-31 | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.04 | 0.06 | 0.14 | 0.18 | 0.25 | |
Net income per share | -0.53 | -0.44 | -0.48 | -1.06 | -0.57 | |
Operating cash flow per share | -0.18 | -0.14 | -0.04 | -0.35 | -0.35 | |
Free cash flow per share | -0.18 | -0.14 | -0.04 | -0.36 | -0.36 | |
Cash per share | 0.08 | 0 | 0.02 | 0.62 | 0.23 | |
Book value per share | 0.39 | 0.03 | 1.06 | 1.49 | 1.01 | |
Tangible book value per share | 0.05 | -0.29 | -0.21 | 0.7 | 0.33 | |
Share holders equity per share | 0.39 | 0.03 | 1.06 | 1.49 | 1.01 | |
Interest debt per share | 0.01 | 0.06 | 0.31 | 0.03 | 0.02 | |
Market cap | 179.84M | 87.01M | 103.94M | 29.75M | 30.88M | |
Enterprise value | 179.4M | 87.32M | 105.57M | 24.99M | 29.08M | |
P/E ratio | -53.99 | -31.13 | -32.34 | -3.53 | -6.42 | |
Price to sales ratio | 733.18 | 234.75 | 110.14 | 20.92 | 14.85 | |
POCF ratio | -162.68 | -97.27 | -349.89 | -10.59 | -10.34 | |
PFCF ratio | -162.07 | -97.27 | -349.89 | -10.29 | -10.07 | |
P/B Ratio | 74.79 | 495.97 | 14.61 | 2.51 | 3.6 | |
PTB ratio | 74.79 | 495.97 | 14.61 | 2.51 | 3.6 | |
EV to sales | 731.41 | 235.59 | 111.87 | 17.57 | 13.98 | |
Enterprise value over EBITDA | -54.46 | -46.5 | -42.31 | -6.92 | -7.69 | |
EV to operating cash flow | -162.29 | -97.62 | -355.4 | -8.9 | -9.73 | |
EV to free cash flow | -161.68 | -97.62 | -355.4 | -8.64 | -9.48 | |
Earnings yield | -0.02 | -0.03 | -0.03 | -0.28 | -0.16 | |
Free cash flow yield | -0.01 | -0.01 | 0 | -0.1 | -0.1 | |
Debt to equity | 0.02 | 1.83 | 0.25 | 0.01 | 0.02 | |
Debt to assets | 0.01 | 0.15 | 0.18 | 0.01 | 0.02 | |
Net debt to EBITDA | 0.13 | -0.17 | -0.66 | 1.32 | 0.48 | |
Current ratio | 1.47 | 0.02 | 0.12 | 7.01 | 3.6 | |
Interest coverage | 0 | -26.83 | -9.25 | -33.19 | -500.41 | |
Income quality | 0.33 | 0.33 | 0.1 | 0.45 | 0.67 | |
Dividend Yield | 0 | 0 | 0 | 0.01 | 0.01 | |
Payout ratio | 0 | 0 | 0 | -0.02 | -0.06 | |
Sales general and administrative to revenue | 0 | 0 | 3.09 | 2.83 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0.29 | 0.47 | |
Intangibles to total assets | 0.74 | 0.93 | 0.86 | 0.49 | 0.61 | |
Capex to operating cash flow | 0 | 0 | 0 | 0.03 | 0.03 | |
Capex to revenue | -0.02 | 0 | 0 | -0.06 | -0.04 | |
Capex to depreciation | -0.11 | 0 | 0 | -0.26 | -0.21 | |
Stock based compensation to revenue | 7.19 | 0.68 | 2.12 | 0.96 | 0.35 | |
Graham number | 2.15 | 0.52 | 3.37 | 5.98 | 3.6 | |
ROIC | -1.36 | -3.99 | -0.32 | -0.45 | -0.5 | |
Return on tangible assets | -4.52 | -17.06 | -2.31 | -1.3 | -1.32 | |
Graham Net | 0.01 | -0.32 | -0.38 | 0.52 | 0.15 | |
Working capital | 187.46K | -1.98M | -2.25M | 4.69M | 1.95M | |
Tangible asset value | 333.61K | -1.86M | -1.42M | 5.58M | 2.77M | |
Net current asset value | 187.46K | -1.98M | -2.5M | 4.58M | 1.81M | |
Invested capital | 0.02 | 1.83 | 0.25 | 0.01 | 0.02 | |
Average receivables | 6.68K | 12.96K | 61.09K | 90.36K | 92.21K | |
Average payables | 152.06K | 531.86K | 856.27K | 790.08K | 587.11K | |
Average inventory | 2.07K | 0 | 26.42K | 92.25K | 180.49K | |
Days sales outstanding | 19.48 | 12.64 | 42.29 | 18.32 | 19.84 | |
Days payables outstanding | 369.41 | 513.11 | 589.52 | 254.33 | 146.82 | |
Days of inventory on hand | 0 | 0 | 33.12 | 52.35 | 62.98 | |
Receivables turnover | 18.74 | 28.88 | 8.63 | 19.92 | 18.4 | |
Payables turnover | 0.99 | 0.71 | 0.62 | 1.44 | 2.49 | |
Inventory turnover | 0 | 75468691.42B | 11.02 | 6.97 | 5.8 | |
ROE | -1.39 | -15.93 | -0.45 | -0.71 | -0.56 | |
Capex per share | 0 | 0 | 0 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-10-31 for Q3
Metric | History | 2022-10-31 | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.08 | 0.06 | 0.06 | 0.08 | 0.05 | |
Net income per share | -0.14 | -0.2 | -0.13 | -0.11 | -0.22 | |
Operating cash flow per share | -0.07 | -0.1 | -0.1 | -0.13 | -0.14 | |
Free cash flow per share | -0.07 | -0.1 | -0.1 | -0.13 | -0.14 | |
Cash per share | 0.36 | 0.23 | 0.16 | 0.3 | 0.16 | |
Book value per share | 1.25 | 1.01 | 0.99 | 0.88 | 0.73 | |
Tangible book value per share | 0.46 | 0.33 | 0.25 | 0.15 | 0 | |
Share holders equity per share | 1.25 | 1.01 | 0.99 | 0.88 | 0.73 | |
Interest debt per share | 0.03 | 0.02 | 0.03 | 0.29 | 0.29 | |
Market cap | 33.4M | 30.88M | 26.24M | 30.55M | 17.62M | |
Enterprise value | 30.78M | 29.08M | 25.19M | 30.48M | 18.61M | |
P/E ratio | -7.73 | -4.63 | -6.46 | -9.21 | -2.5 | |
Price to sales ratio | 54.04 | 58.53 | 55.02 | 46.57 | 41.19 | |
POCF ratio | -64.17 | -37.93 | -34.99 | -30.7 | -16.56 | |
PFCF ratio | -64.02 | -37.47 | -34.87 | -30.7 | -16.56 | |
P/B Ratio | 3.43 | 3.6 | 3.4 | 4.43 | 3.09 | |
PTB ratio | 3.43 | 3.6 | 3.4 | 4.43 | 3.09 | |
EV to sales | 49.81 | 55.12 | 52.81 | 46.47 | 43.51 | |
Enterprise value over EBITDA | -32.09 | -22.62 | -27.11 | -41.37 | -11.16 | |
EV to operating cash flow | -59.14 | -35.72 | -33.59 | -30.63 | -17.49 | |
EV to free cash flow | -59 | -35.29 | -33.47 | -30.63 | -17.49 | |
Earnings yield | -0.03 | -0.05 | -0.04 | -0.03 | -0.1 | |
Free cash flow yield | -0.02 | -0.03 | -0.03 | -0.03 | -0.06 | |
Debt to equity | 0.02 | 0.02 | 0.03 | 0.33 | 0.39 | |
Debt to assets | 0.02 | 0.02 | 0.03 | 0.23 | 0.26 | |
Net debt to EBITDA | 2.73 | 1.4 | 1.14 | 0.09 | -0.59 | |
Current ratio | 4.44 | 3.6 | 2.54 | 3.74 | 2.79 | |
Interest coverage | -270.18 | 321.68 | -321.5 | -89.25 | -42.87 | |
Income quality | 0.48 | 0.48 | 0.74 | 1.2 | 0.6 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.7 | 1.99 | 0 | 0 | 0 | |
Research and developement to revenue | 0.47 | 0.56 | 0.84 | 0.68 | 1.29 | |
Intangibles to total assets | 0.58 | 0.61 | 0.67 | 0.58 | 0.67 | |
Capex to operating cash flow | 0 | 0.01 | 0 | 0 | 0 | |
Capex to revenue | 0 | -0.02 | -0.01 | 0 | 0 | |
Capex to depreciation | -0.01 | -0.14 | -0.03 | 0 | 0 | |
Stock based compensation to revenue | 0.66 | 1.39 | 0.34 | 0 | 1.36 | |
Graham number | 1.97 | 2.12 | 1.7 | 1.45 | 1.92 | |
ROIC | -0.11 | -0.15 | -0.13 | -0.09 | -0.22 | |
Return on tangible assets | -0.24 | -0.46 | -0.35 | -0.2 | -0.63 | |
Graham Net | 0.26 | 0.15 | 0.07 | -0.05 | -0.17 | |
Working capital | 2.72M | 1.95M | 1.21M | 2.4M | 1.28M | |
Tangible asset value | 3.57M | 2.77M | 1.95M | 1.15M | -5.94K | |
Net current asset value | 2.57M | 1.81M | 1.04M | 291.65K | -812K | |
Invested capital | 0.02 | 0.02 | 0.03 | 0.33 | 0.39 | |
Average receivables | 113.51K | 96.75K | 138.84K | 194.05K | 196.56K | |
Average payables | 267.92K | 535.26K | 539.22K | 520.27K | 442.32K | |
Average inventory | 173.08K | 206.83K | 205.42K | 169.21K | 165.78K | |
Days sales outstanding | 11.72 | 19.29 | 31.07 | 30.66 | 35.69 | |
Days payables outstanding | 138.07 | 120.87 | 192.18 | 125.5 | 129.81 | |
Days of inventory on hand | 47.5 | 51.84 | 64.15 | 39.64 | 58.45 | |
Receivables turnover | 7.68 | 4.67 | 2.9 | 2.94 | 2.52 | |
Payables turnover | 0.65 | 0.74 | 0.47 | 0.72 | 0.69 | |
Inventory turnover | 1.89 | 1.74 | 1.4 | 2.27 | 1.54 | |
ROE | -0.11 | -0.19 | -0.13 | -0.12 | -0.31 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
NTRBW Frequently Asked Questions
What is Nutriband Inc. stock symbol ?
Nutriband Inc. is a US stock , located in Orlando of Fl and trading under the symbol NTRBW
What is Nutriband Inc. stock quote today ?
Nutriband Inc. stock price is $0.92 today.
Is Nutriband Inc. stock public?
Yes, Nutriband Inc. is a publicly traded company.